REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,002.00
Bid: 2,002.00
Ask: 2,004.00
Change: -10.00 (-0.50%)
Spread: 2.00 (0.10%)
Open: 2,014.00
High: 2,024.00
Low: 1,996.00
Prev. Close: 2,012.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: US-China Hopes Boost Market; BOE Holds UK Rates

Thu, 07th Nov 2019 12:03

(Alliance News) - Stock prices in London were on the rise on Thursday at midday as sentiment was boosted on the news the two world's largest economies might finally be heading towards a deal to end their ongoing trade spat.

Closer to home, the Bank of England kept UK interest rates unchanged at 0.75%, but two out of 9 policy makers voted to cut rates.

The pound was quoted at USD1.2824 at midday Thursday, down from USD1.2866 late on Wednesday.

The Chinese Commerce Ministry said Thursday the pair have agreed a plan to remove tariffs imposed on two-way goods in stages. But there also has been growing hope that they are close to reaching a mini agreement as part of a wider trade deal.

"In the past two weeks, the negotiation leaders of the two sides have held serious and constructive discussions on properly resolving their core concerns and agreed to roll back the additional tariffs in stages, as progress is made towards a [final] agreement," ministry spokesman Gao Feng told a news conference.

The FTSE 100 was 15.93 points higher, or 0.2%, at 7,412.80 Thursday midday. The FTSE 250 was up 177.80 points, or 0.9%, at 20,394.39, and the AIM All-Share was up 0.1% at 891.98.

The Cboe UK 100 index was up 0.3% at 12,563.89. The Cboe UK 250 was up 1.1% at 18,297.07 and the Cboe UK Small Companies was up 0.2% at 11,264.83.

In European equities, the CAC 40 index in Paris was up 0.2% and the DAX 30 in Frankfurt was 0.7% higher.

"European stocks are on the rise this morning, with the early doubts over a potential delay to the phase one US-China trade deal being cast aside after the Chinese laid out a strategy for de-escalating their relationship with the US," said IG senior market analyst Joshua Mahony.

"While a final deal could be signed in December rather than November, the plan to begin rolling back tariffs across the phases does show that we are finally seeing light at the end of the tunnel. Unlike the promise of higher agricultural purchases by the Chinese, a roll back in tariffs from each side would be much more positive for the wider economy and less likely to falter due to non-conformity of the agreement. Optimism over those US-China talks has understandably boosted risk sentiment, with stocks and the yuan gaining ground at the detriment of havens such as gold and the Japanese yen."

Wall Street is pointed to a big open as a result, with the S&P 500 set to open 0.4% higher, the Nasdaq Composite 0.5% and the Dow Jones Industrial Average 0.6%.

On the London Stock Exchange, RSA Insurance was biggest large-cap riser, up 3.5%, after the general insurer reported flat premiums in the first nine months of 2019 despite "challenging" market conditions.

The London-headquartered company said insurance market conditions were largely unchanged in the third quarter, but financial markets continue to present challenges, particularly from lower bond yields. The company's net written premiums in the year-to-date of GBP4.87 billion were flat year-on-year and broadly in line with expectations.

"RSA's results to end September are strong, and consistent with our plans for the period. Current year underwriting results have sharply improved, with all our regional businesses contributing," said Chief Executive Stephen Hester.

Housebuilder Persimmon was 2.9% higher as trading over the summer met expectations.

Persimmon said business has been "resilient" in the second half of 2019, and the company is now fully sold for the current year. Some GBP950 million of forward sales are secured beyond 2019, compared to GBP987 million this time a year ago.

Sales volumes for the first half of 2019 dipped 6% year-on-year to 7,584 homes, but this was due to an approach of selling homes only when they are at an advanced stage of construction. Persimmon expects second-half sales to be above the first half.

Auto Trader was up 1.3% after the car marketplace lifted its dividend on the back of a 12% increase in first-half profit and said it remains confident in meeting growth expectations for financial 2020 despite ongoing market uncertainty.

For the six months to September 30, Auto Trader recorded a 12% rise in pretax profit to GBP127.7 million, on revenue of GBP186.7 million, up 6%.

Also among the blue-chip risers were miners, benefiting from the positive US-China trade news.

Glencore was up 1.7%, Anglo American up 1.3% and Antofagasta up 1.2%. Steel maker Evraz was 2.3% higher.

At the other end of the FTSE 100, Hiscox was by far the worst performer, losing 14%, after JPMorgan has cut its rating on the insurer to Neutral from Overweight. Jefferies cut its price target on the stock by 23%, keeping a Hold rating.

Joining Hiscox at the bottom of the blue-chip index was Hikma Pharmaceutical, down 2.0% despite the generic drug maker reiterating annual guidance amid "strong" performance across all divisions.

The London-headquartered company said it is benefiting from its "broad and differentiated" product portfolios, strong commercial capabilities, and tight cost control.

SSE was down 1.8% after Berenberg cut the electricity utility to Hold from Buy.

In the midcaps, Bank of Georgia was the best performer, up 8.7% after the lender reported a 1.8% rise in net interest income for the third quarter to GEL188.7 million, about GBP49.6 million, with net fee and commission income up 22%.

Pretax profit climbed 30% to GEL157.0 million. Bank of Georgia said it was an "excellent" quarter of growth, with improved asset quality and profitability.

John Wood Group was 7.4% higher. The oil field services firm said ongoing cost-cutting measures are benefiting overall performance in a weak market.

John Wood confirmed 2019 earnings before interest, taxes, depreciation, and amortisation performance is tracking market consensus despite a "slowing macro environment".

Tate & Lyle was up 6.7% after it said it expects to deliver earnings growth in its current financial year following a surge in profit in the first half.

The company reported a pretax profit for the six months to the end of September of GBP164 million, 45% higher compared to a year ago, as sales grew by 6.7% to GBP1.48 billion.

Tate & Lyle increased its interim payout to 8.8 pence a share from 8.6p paid a year prior.

Engineering firm IMI was 6.4%. It said it has put lower-margin businesses worth 20% to 30% of group revenue under review, and it is targeting a further GBP35 million of annualised savings.

IMI has found "significant value creation opportunities" across the business after completing a group-wide review. The company said organic revenue for the three months to September 30 was 2% lower year-on-year and flat on an adjusted basis.

Despite the lower sales, IMI achieved higher margins in the third quarter, adding that units have "acted decisively" to reduce costs and protect margins.

Sinking to the bottom of the FTSE 250, Senior lost 5.1% after the engineering firm announced it is implementing a restructuring to drive improved results as it deals with challenges in the Flexonics and Aerospace markets.

The manufacturer of high-technology components and systems said the restructuring will result in around GBP20 million of savings, "with a significant portion coming from headcount reductions as we match capacity to demand", the company said.

Senior said sales grew in Aerospace in the first ten months of 2019 from a year before but revenue in the last four months, July to October, has been lower than expected due to weakened demand in the commercial aircraft engine market. Senior's Flexonics division has been performing in line with expectations with "markets weakening in the last four months as anticipated."

Luxury car maker Aston Martin Lagonda was struggling, down 1.2%, after warning of "tough trading conditions" hurting sales.

For the third quarter of 2019, Aston Martin's wholesale volumes slumped 16% to 1,497 vehicles, with the nine-month figure down 3% to 3,939.

This led to an 11% drop in third-quarter revenue to GBP250.1 million, and for the nine months there was a 7% decline to GBP657.2 million.

Gaydon, Warwickshire-based Aston Martin posted a quarterly pretax loss of GBP13.5 million, swung from a GBP3.1 million profit a year ago, and a nine month to September 30 pretax loss of GBP92.3 million from a profit of GBP23.9 million.

Looking ahead, Aston Martin expects to meet the market's financial expectations for 2019 despite the lower volumes. For 2019, Aston Martin sees total wholesales to be lower than previously guided, but still within market expectations.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.